[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356520-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356520-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","nanotechnology-for-reproductive-healthcare-a-comprehensive-review","Nanotechnology for reproductive healthcare - a comprehensive review","","Nanotechnology for reproductive healthcare addresses major clinical barriers in infertility, endometriosis, ectopic pregnancy, reproductive-tract infections, and related malignancies, where conventional diagnostics and therapies often show low specificity, systemic toxicity, and inefficient delivery. The review explains how engineered nanomaterials enable improved imaging, early diagnosis, personalized drug administration, targeted delivery, and enhanced fertility preservation while reducing side effects via nanoparticle-based systems. Ongoing clinical trials and evolving synthesis approaches are assessed, aiming to summarize current advances and future directions in nanocarriers for reproductive disorders.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/nanotechnology-for-reproductive-healthcare-a-comprehensive-review/356520/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/nanotechnology-for-reproductive-healthcare-a-comprehensive-review/356520.png","ImageObject",300,407,{"name":42,"@type":43},"Mia  ","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Nanotechnology is improving which areas of reproductive healthcare?","Question",{"text":63,"@type":64},"It supports treatment of conditions such as infertility, endometriosis, ectopic pregnancies, erectile dysfunction, STIs, and reproductive tissue cancers, and it also enables improved imaging, early diagnosis, and fertility preservation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do nanocarriers enhance drug delivery and outcomes?",{"text":68,"@type":64},"Engineered nanomaterials provide improved stability, better pharmacokinetics, and targeted delivery to reproductive organs, while nanoparticle drug-delivery systems can increase effectiveness and reduce side effects.",{"name":70,"@type":61,"acceptedAnswer":71},"What limits clinical translation of these nanotechnology approaches?",{"text":72,"@type":64},"Clinical translation remains limited due to gaps in reproductive toxicology data, challenges in long-term biocompatibility, and the lack of standardized regulatory frameworks.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356520,1790390324,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687207024478,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Koduru etal. Journal of Nanobiotechnology (2026) 24:262  \n[https://doi.org/10.1186/s12951-025-03898-7](https://doi.org/10.1186/s12951-025-03898-7)  \nJournal of Nanobiotechnology  \nREVIEW Open Access  \nNanotechnology for reproductive healthcare:  a comprehensive review  \nRamesh Koduru 1, Somedutta Maity2, Dibakar Das2, Ramachandra Reddy Pamuru1*, Arifullah Mohammed3 and Gooty Jaffer Mohiddin4*  \nAbstract  \nThe advancement of nanotechnology has revolutionized reproductive healthcare worldwide. It has enabled the treatment of various conditions, such as infertility, endometriosis, ectopic pregnancies, erectile dysfunction, sexually transmitted infections (STIs), and reproductive tissue cancers. Nanotechnology offers improved imaging, personalized drug administration, and early diagnosis, leading to more accurate treatment outcomes. It can enhance fertility preservation, improve individualized therapy, and improve diagnostic methods. Additionally, nanotechnology-powered drug delivery systems increase effectiveness while reducing side effects. Clinical trials utilizing nanoparticles for cellular treatments, targeted drug delivery, early infection detection, reproductive system malignancies and precise medication delivery are currently underway. Nanotechnology has opened new possibilities in areas such as disease detection, drug administration, diagnostic imaging, and cancer treatment. This review aims to provide an overview of the different types, characteristics, and synthesis methods of nanocarriers designed for medication delivery in the context of reproductive disorders and diseases. It seeks to enhance the understanding of the current state of the art and explore potential future advancements in this field.  \nKeywords Nanotechnology, Reproductive health, Targeted drug delivery, Biosensor  \nIntroduction  \nReproductive medicine continues to confront substantial clinical challenges. Conditions such as infertility, endometriosis, polycystic ovary syndrome (PCOS), preeclampsia, and reproductive-tract infections affect millions worldwide and are often resistant to current diagnostic and therapeutic modalities [1–3]. Traditional approaches frequently suffer from low specificity, systemic toxicity, and inefficient delivery of therapeuticsto reproductive tissues [4]. Furthermore, the intricate  \n*Correspondence: Ramachandra Reddy Pamuru[reddyprbiotech@gmail.com](reddyprbiotech@gmail.com)[ ](reddyprbiotech@gmail.com)Gooty Jaffer Mohiddin [jgooty@espe.edu.ec](jgooty@espe.edu.ec)  \nFull list of author information is available at the end of the article  \nphysiology of the reproductive tract, the immunological complexity of pregnancy, and the ethical constraints surrounding gamete and embryo manipulation underscore the need for novel, precision-based interventions ([5].– [6])  \nNanotechnology offers a transformative framework to address these unmet needs. Engineered nanomaterials—such as liposomes, polymeric nanoparticles, dendrimers, and metallic nanostructures—exhibit unique physicochemical characteristics that enhance drug stability, improve pharmacokinetics, and enable targeted delivery to specific reproductive organs [7, 8]. The clinical success of nanocarrier platforms in oncology and infectious diseases (e.g., liposomal doxorubicin, lipid-nanoparticle mRNA vaccines) provides a compelling precedent for their application in reproductive health [9].  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this","cbCaiphvmGgAVKAr","https://ap.wps.com/l/cbCaiphvmGgAVKAr","pdf",7187613,34,"English","# Introduction\n# Nanotechnology-based advances in reproductive healthcare\n## Targeted drug delivery and diagnostic imaging\n## Nanocarriers and therapeutic platforms\n# Conclusion and future directions","[{\"question\":\"Nanotechnology is improving which areas of reproductive healthcare?\",\"answer\":\"It supports treatment of conditions such as infertility, endometriosis, ectopic pregnancies, erectile dysfunction, STIs, and reproductive tissue cancers, and it also enables improved imaging, early diagnosis, and fertility preservation.\"},{\"question\":\"How do nanocarriers enhance drug delivery and outcomes?\",\"answer\":\"Engineered nanomaterials provide improved stability, better pharmacokinetics, and targeted delivery to reproductive organs, while nanoparticle drug-delivery systems can increase effectiveness and reduce side effects.\"},{\"question\":\"What limits clinical translation of these nanotechnology approaches?\",\"answer\":\"Clinical translation remains limited due to gaps in reproductive toxicology data, challenges in long-term biocompatibility, and the lack of standardized regulatory frameworks.\"}]","Nanotechnology for reproductive healthcare - a comprehensive review | PDF",1790125779,86,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7e954c3e49fb0c1c3dc44b2f29cc0fb7.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/23a7c41922c6960dc9644621e55ba818.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9bbf31e1e47ab6bf2786d9ce1791ae0a.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/03f55fe39ad75c65fb88bc0cec706444.webp",980,1306]